1-832-868-1888
order@swbio.com

Catalog Number: |
42577 |
| other_names: | Receptor for advanced glycosylation end products, AGER, RAGE |
Amount: |
100μg |
| calculated_mw: | 44kd |
| host_species: | Rabbit |
Price: |
$319 |
Swiss-Prot No: |
Swiss-Prot#: Q15109 |
Form of Antibody: |
Preservative: 0.03% Proclin 300 Constituents: 50% Glycerol, 0.01M PBS, PH 7.4 |
Storage/Stability: |
|
Immunogen: |
Recombinant human Advanced glycosylation end product-specific receptor protein |
Purification: |
Caprylic Acid Ammonium Sulfate Precipitation purified |
Specificity/Sensitivity: |
The antibody detects endogenous level of total Advanced glycosylation end product-specific receptor polyclonal antibody. |
Applications: |
WB IHC |
Background: |
Mediates interactions of advanced glycosylation end products (AGE). These are nonenzymatically glycosylated proteins which accumulate in vascular tissue in aging and at an accelerated rate in diabetes. Acts as a mediator of both acute and chronic vascular inflammation in conditions such as atherosclerosis and in particular as a complication of diabetes. AGE/RAGE signaling plays an important role in regulating the production/expression of TNF-alpha, oxidative stress, and endothelial dysfunction in type 2 diabetes. Interaction with S100A12 on endothelium, mononuclear phagocytes, and lymphocytes triggers cellular activation, with generation of key proinflammatory mediators. Interaction with S100B after myocardial infarction may play a role in myocyte apoptosis by activating ERK1/2 and p53/TP53 signaling By similarity. Receptor for amyloid beta peptide. Contributes to the translocation of amyloid-beta peptide (ABPP) across the cell membrane from the extracellular to the intracellular space in cortical neurons. ABPP-initiated RAGE signaling, especially stimulation of p38 mitogen-activated protein kinase (MAPK), has the capacity to drive a transport system delivering ABPP as a complex with RAGE to the intraneuronal space. |
References: |
[1] "Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins."Neeper M., Schmidt A.M., Brett J., Yan S.D., Wang F., Pan Y.C., Elliston K., Stern D., Shaw A.J. Biol. Chem. 267:14998-15004(1992) [2] & |
appl_detail: |
Western blotting: 1:500 - 1:1000 |
QUICK LINKS
Unique Antibodies Cancer/Apoptosis antibody Tag Antibody Neuroscience antibody MAP kinase antibody Secondary AntibodyCONTACT US
1-832-868-1888 order@swbio.com



GET IN TOUCH